Bovine-derived polyclonal antibodies exhibit high efficacy in neutralizing SARS-CoV-2 variants

By | June 10, 2021
A team of scientists in Estonia has recently evaluated the therapeutic/prophylactic efficacy of anti-SARS-CoV-2 polyclonal antibodies derived from the colostrum of immunized cows.